Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 | New England Journal of Medicine | 2020 | 1.3K |
Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis | BMJ, The | 2020 | 174 |
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people | Heart | 2020 | 174 |
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology | EBioMedicine | 2020 | 155 |
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes | JAMA - Journal of the American Medical Association | 2020 | 155 |
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure | Circulation | 2020 | 145 |
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure | Nature Communications | 2020 | 140 |
The 'Digital Twin' to enable the vision of precision cardiology | European Heart Journal | 2020 | 136 |
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials | Lancet, The | 2020 | 133 |
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial | Circulation | 2020 | 130 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust | European Journal of Heart Failure | 2020 | 127 |
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study | Journal of Infection | 2020 | 115 |
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group | European Heart Journal | 2020 | 106 |
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19 | Circulation | 2020 | 106 |
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial | Nephrology Dialysis Transplantation | 2020 | 105 |
The Polygenic and Monogenic Basis of Blood Traits and Diseases | Cell | 2020 | 96 |
Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations | Cell | 2020 | 88 |
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure | European Journal of Heart Failure | 2020 | 85 |
The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic | European Journal of Heart Failure | 2020 | 84 |
Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update) | Diabetes/Metabolism Research and Reviews | 2020 | 79 |
Mental health in UK Biobank - development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis | BJPsych Open | 2020 | 76 |
Acute heart failure | Nature Reviews Disease Primers | 2020 | 70 |
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF | JACC: Heart Failure | 2020 | 61 |
Oxidative Stress: A Unifying Paradigm in Hypertension | Canadian Journal of Cardiology | 2020 | 57 |
Definitions and criteria for diabetic foot disease | Diabetes/Metabolism Research and Reviews | 2020 | 57 |